Gene · 7337
Papers4,306
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 4,306
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epilepsy phenotype and gene ontology analysis of the 129 genes in a large neurodevelopmental disorders cohort. | Front Neurol | 2023 | 37645600 | PubTator, text mining | PubMed |
| Forensic DNA Phenotyping: Genes and Genetic Variants for Eye Color Prediction. | Genes (Basel) | 2023 | 37628655 | PubTator, text mining | PubMed |
| Prenatal Chromosomal Microarray Analysis: Does Increased Resolution Equal Increased Yield? | Genes (Basel) | 2023 | 37628571 | PubTator, text mining | PubMed |
| Ubiquitin Engineering for Interrogating the Ubiquitin-Proteasome System and Novel Therapeutic Strategies. | Cells | 2023 | 37626927 | PubTator, text mining | PubMed |
| Novel epigenetic molecular therapies for imprinting disorders. | Mol Psychiatry | 2023 | 37626134 | PubTator, text mining | PubMed |
| Potential roles of NEDD4 and NEDD4L and their utility as therapeutic targets in high‑incidence adult male cancers (Review). | Mol Clin Oncol | 2023 | 37614371 | PubTator, text mining | PubMed |
| Histone modifications in embryo implantation and placentation: insights from mouse models. | Front Endocrinol (Lausanne) | 2023 | 37600694 | PubTator, text mining | PubMed |
| The neurological and non-neurological roles of the primary microcephaly-associated protein ASPM. | Front Neurosci | 2023 | 37599996 | PubTator, text mining | PubMed |
| Current and emerging treatment options for Angelman syndrome. | Expert Rev Neurother | 2023 | 37599585 | PubTator, text mining | PubMed |
| Application of Human Brain Organoids-Opportunities and Challenges in Modeling Human Brain Development and Neurodevelopmental Diseases. | Int J Mol Sci | 2023 | 37569905 | PubTator, text mining | PubMed |
| A cryptic microdeletion del(12)(p11.21p11.23) within an unbalanced translocation t(7;12)(q21.13;q23.1) implicates new candidate loci for intellectual disability and Kallmann syndrome. | Sci Rep | 2023 | 37563198 | PubTator, text mining | PubMed |
| Profiling and verifying the substrates of E3 ubiquitin ligase Rsp5 in yeast cells. | STAR Protoc | 2023 | 37561636 | PubTator, text mining | PubMed |
| Auranofin targets UBA1 and enhances UBA1 activity by facilitating ubiquitin trans-thioesterification to E2 ubiquitin-conjugating enzymes. | Nat Commun | 2023 | 37558718 | PubTator, text mining | PubMed |
| A pancancer analysis of the oncogenic role of ZNRF2 in human tumours. | J Cell Mol Med | 2023 | 37551845 | PubTator, text mining | PubMed |
| Ubiquitin-protein ligase E3A (UBE3A) mediation of viral infection and human diseases. | Virus Res | 2023 | 37541588 | PubTator, text mining | PubMed |
| Structural Basis for the Enzymatic Activity of the HACE1 HECT-Type E3 Ligase Through N-Terminal Helix Dimerization. | Adv Sci (Weinh) | 2023 | 37537642 | PubTator, text mining | PubMed |
| Effects of high-risk human papillomavirus infection on P53, pRb, and survivin in lung adenocarcinoma-a retrospective study. | PeerJ | 2023 | 37520249 | PubTator, text mining | PubMed |
| Design of a Synthetic Long Peptide Vaccine Targeting HPV-16 and -18 Using Immunoinformatic Methods. | Pharmaceutics | 2023 | 37513985 | PubTator, text mining | PubMed |
| The TP53 Codon 72 Arginine Polymorphism Is Found with Increased TP53 Somatic Mutations in HPV(-) and in an Increased Percentage among HPV(+) Norwegian HNSCC Patients. | Biomedicines | 2023 | 37509476 | PubTator, text mining | PubMed |
| HPV16 E6/E7 -based mRNA vaccine is therapeutic in mice bearing aggressive HPV-positive lesions. | Front Immunol | 2023 | 37503351 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7337/papers?page=17